In 2020, the Chinese orthobiologics marketsize was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026.
Throughout this medical market research, we analyzed 28 orthobiologics companies across China and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Chinese Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.
In the past, lower-tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.
By 2020, the leading competitor in the Chinese orthopedic biomaterials market was Kunming Baker Norton, which was attributed to its leading position in the HA viscosupplementation market. Kunming Baker Norton’s portfolio includes the five-injection ARTZ® product line, which is originally manufactured by Seikagaku.
Haohai Biologic Technology was the second-leading competitor in the Chinese market. The company held the second-leading position in the three-injection HA viscosupplementation market and the third-leading position in the five-injection HA viscosupplementation market.
Click on each title to view more detailed market segmentation.
Procedure Volumes for Orthopedic Biomaterials Devices – MedPro – The Complete procedural analysis for each segment of the Chinese Orthopedic Biomaterials market.
Orthopedic Bone Graft Substitute Market – MedCore – This market is further segmented by Material Type, including Allograft, Demineralized Bone Matrix Allograft, and Synthetic. Each of these Material Types is segmented by Spine, Trauma, Large Joint Reconstruction, Craniomaxillofacial, and Oncology.
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:
Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.